Very excited to be launching Open-IBD today, on #worldIBDday .

We will recruit 1000 newly diagnosed IBD patients and follow them for up to 4 years. Via dense biological sampling we aim to build predictors of disease course and treatment response and ID new drug targets. #ddw2024

📢 On World #IBD Day weekend Carl Anderson and I are delighted to introduce Open-IBD!

£11M funding from Open Targets and Wellcome Sanger Institute

Open-IBD will study serial multi-omics and longterm outcomes from diagnosis in 1,000 people with IBD

More👇

opentargets.org/news/open-ibd-…

Launching ahead of #WorldIBDDay , Open-IBD is an ambitious project that aims to uncover new ways to predict, monitor, and treat #Crohnsdisease and #ulcerativecolitis 🔎

Read more about it here 👇
sanger.ac.uk/news_item/ambi…

📣Introducing Open-IBD — our most ambitious project yet!

Open-IBD will bring together genomics and immunology experts, gastroenterologists, and patients from across the UK to identify new and personalised ways to predict, monitor, and treat inflammatory bowel disease

Welcome back to campus Julio Saez-Rodriguez ! I look forward to working with you 😊

Have you recently completed a PhD in immunology? Do you like Tregs, CRISPR and all things genomics? Then look no further! This could be your opportunity to join us at the the Sanger!

A fantastic postdoc opportunity to bridge two groups at Sanger. We have an exciting project, co-developed with Carl Anderson to deploy large scale CRISPR and single-cell transcrptomics to understand IBD genes in Tregs. We're looking for an immunologist to lead this effort!

We will be looking for new group leaders, with focus on (AI) methods, and especially young scientists. We evaluate by potential not just your current track record - great place to start a lab (speaking from experience!) - contact if interested, & please RT

Delighted to welcome MSD to Open Targets consortium. An additional industry partner brings new perspective to our active academic-industry dialogue and strengthens the science that we do. Welcome to the team and I look forward to working with our new colleagues!

Beautiful work from the very talented Megan Gozzard ! And check out her website 😍

Out now! Together with members of our Exec & Science Leadership Team EMBL-EBI Wellcome Sanger Institute GSK Genentech Pfizer Inc. Bristol Myers Squibb Sanofi we share our perspective on how Open Targets we use human genetics & genomics for drug target ID & prioritisation: annualreviews.org/content/journa…

I look forward to visiting Kennedy Institute of Rheumatology in beautiful Oxford on Monday. Looking forward to lots of science discussions. Thank you Yang Luo for hosting me 😊 See you on Monday!

This is a great postdoc opportunity to join an excellent lab, with plenty of support and cutting edge science in immunoregulation #crispr #scRNAseq One of its kind collaborative efforts between multiple labs and industry! Open Targets Apply or get in touch for more information.

Fascinating work, congrats Teng and the team!

Amazing #postdoc position alert in our group EMBL-EBI! Funded by Open Targets , collaboration with the Garnett Lab Wellcome Sanger Institute and industry partners. We have produced the largest dataset to date of dual CRISPR perturbations (65K pairs, 45 cell lines, 2 tissue types) and are

Oooh, neat effort! Onto digging into the preprints now.

Many new features in this new release of Open Targets Platform!

Open Targets turns 10! It's a true pleasure to be a part of this unique academic-industry partnership! Great science, great community! Here's to another 10 years! 🥂🎉

En este #8M en JAGUAR reconocemos el papel crucial que las mujeres han desempeñado en la ciencia a lo largo de la historia.

Honramos a quienes han desafiado las barreras y están dejando su huella, construyendo una sociedad más justa y equitativa.

#NoMasCienciaSinNosotras

En este #8M2024 quiero reconocer y agradecer a las mujeres que conforman el laboratorio y con quienes tengo el privilegio de trabajar y aprender cada día

Va hilo🧵